Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1507)
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
18,000
Price
$30.26
Total Value
$544.60K
Shares Held After
56,450
% of Holdings
24.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
3,700
Price
$30.26
Total Value
$111.95K
Shares Held After
56,450
% of Holdings
6.2%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
670
Price
$31.03
Total Value
$20.79K
Shares Held After
355,167
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
28,400
Price
$30.30
Total Value
$860.59K
Shares Held After
355,837
% of Holdings
7.4%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,511
Price
$2.69
Total Value
$4.06K
Shares Held After
6,236
% of Holdings
24.2%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,034
Price
$2.69
Total Value
$5.47K
Shares Held After
6,013
% of Holdings
33.8%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,190
Price
$2.69
Total Value
$5.89K
Shares Held After
6,498
% of Holdings
33.7%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,748
Price
$2.69
Total Value
$4.70K
Shares Held After
6,441
% of Holdings
27.1%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
8,457
Price
$13.23
Total Value
$111.85K
Shares Held After
423
% of Holdings
95.2%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,706
Price
$2.69
Total Value
$4.59K
Shares Held After
13,813
% of Holdings
12.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$579.51
Total Value
$23.18K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
460
Price
$577.97
Total Value
$265.87K
Shares Held After
40,553
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
316
Price
$577.10
Total Value
$182.36K
Shares Held After
41,013
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
424
Price
$576.14
Total Value
$244.28K
Shares Held After
41,329
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
312
Price
$574.79
Total Value
$179.34K
Shares Held After
41,753
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
928
Price
$573.85
Total Value
$532.53K
Shares Held After
42,065
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,640
Price
$572.57
Total Value
$939.02K
Shares Held After
42,993
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,826
Price
$571.59
Total Value
$2.19M
Shares Held After
44,633
% of Holdings
7.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,194
Price
$570.76
Total Value
$681.48K
Shares Held After
48,459
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$569.54
Total Value
$205.03K
Shares Held After
49,653
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$578.76
Total Value
$23.15K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
378
Price
$578.07
Total Value
$218.51K
Shares Held After
18,916
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
336
Price
$577.24
Total Value
$193.95K
Shares Held After
19,294
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
486
Price
$576.24
Total Value
$280.05K
Shares Held After
19,630
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
273
Price
$574.96
Total Value
$156.97K
Shares Held After
20,116
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
887
Price
$574.07
Total Value
$509.20K
Shares Held After
20,389
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
880
Price
$573.00
Total Value
$504.24K
Shares Held After
21,276
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,034
Price
$572.00
Total Value
$1.74M
Shares Held After
22,156
% of Holdings
12.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,940
Price
$571.23
Total Value
$1.68M
Shares Held After
25,190
% of Holdings
10.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
484
Price
$570.19
Total Value
$275.97K
Shares Held After
28,130
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
262
Price
$569.24
Total Value
$149.14K
Shares Held After
28,614
% of Holdings
0.9%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
200
Price
$1.68
Total Value
$336.00
Shares Held After
700
% of Holdings
28.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
101
Price
$158.15
Total Value
$15.97K
Shares Held After
4,666
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
340
Price
$157.37
Total Value
$53.51K
Shares Held After
4,767
% of Holdings
6.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
517
Price
$156.59
Total Value
$80.96K
Shares Held After
5,107
% of Holdings
9.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
42
Price
$155.68
Total Value
$6.54K
Shares Held After
5,624
% of Holdings
0.7%
Processa Pharmaceuticals, Inc. (PCSA)
Bigora Sian — Chief Development Officer
Shares
1,986
Price
$2.69
Total Value
$5.34K
Shares Held After
7,496
% of Holdings
26.5%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,082
Price
$99.57
Total Value
$107.73K
Shares Held After
59,634
% of Holdings
1.8%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
4,418
Price
$99.13
Total Value
$437.96K
Shares Held After
60,716
% of Holdings
6.8%
Heartflow, Inc. (HTFL)
Bain Capital Life Sciences Investors, LLC — 10% Owner
Shares
56,224
Price
$30.05
Total Value
$1.69M
Shares Held After
8,448,158
% of Holdings
0.7%
Heartflow, Inc. (HTFL)
Bain Capital Life Sciences Investors, LLC — 10% Owner
Shares
892,533
Price
$29.18
Total Value
$26.04M
Shares Held After
8,504,382
% of Holdings
9.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,235
Price
$53.32
Total Value
$65.85K
Shares Held After
74,760
% of Holdings
1.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
5,805
Price
$52.65
Total Value
$305.62K
Shares Held After
75,995
% of Holdings
7.1%
Kiniksa Pharmaceuticals International, plc (KNSA)
Patel Sanj K — Director
Shares
2,141
Price
$54.01
Total Value
$115.64K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,736
Price
$6.08
Total Value
$34.87K
Shares Held After
277,569
% of Holdings
2.0%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
3,214
Price
$16.65
Total Value
$53.50K
Shares Held After
120,399
% of Holdings
2.6%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,214
Price
$16.65
Total Value
$53.50K
Shares Held After
31,847
% of Holdings
9.2%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,388
Price
$16.65
Total Value
$39.75K
Shares Held After
51,647
% of Holdings
4.4%
Anika Therapeutics, Inc. (ANIK)
Griffin Stephen D. — Director
Shares
12,200
Price
$12.29
Total Value
$149.88K
Shares Held After
36,163
% of Holdings
33.7%
GE HealthCare Technologies Inc. (GEHC)
Jimenez Frank R — GC & Corporate Secretary
Shares
1,750
Price
$60.45
Total Value
$105.79K
Shares Held After
93,932
% of Holdings
1.9%
Showing 1001–1050 of 1507 transactions (page 21 of 31)